CINECA IRIS Institutional Research Information System

DE BORTOLI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.442
EU - Europa 3.284
AS - Asia 1.043
AF - Africa 146
SA - Sud America 41
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 12.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.258
IT - Italia 1.437
SE - Svezia 536
CN - Cina 505
BG - Bulgaria 386
DE - Germania 219
GB - Regno Unito 218
VN - Vietnam 196
CA - Canada 177
SG - Singapore 156
FI - Finlandia 96
AT - Austria 93
CI - Costa d'Avorio 90
UA - Ucraina 82
TR - Turchia 69
HK - Hong Kong 46
CH - Svizzera 45
FR - Francia 31
PL - Polonia 29
NL - Olanda 27
RU - Federazione Russa 25
NG - Nigeria 23
SN - Senegal 23
BE - Belgio 20
IN - India 19
ES - Italia 17
AU - Australia 14
BR - Brasile 13
KR - Corea 11
JP - Giappone 10
NO - Norvegia 10
EG - Egitto 8
IR - Iran 8
AR - Argentina 7
CO - Colombia 7
MX - Messico 7
CL - Cile 6
EU - Europa 6
EC - Ecuador 5
AE - Emirati Arabi Uniti 4
GR - Grecia 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
AZ - Azerbaigian 2
DK - Danimarca 2
ID - Indonesia 2
IL - Israele 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
IE - Irlanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PK - Pakistan 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.978
Salva come PNG Salva come JPEG
Città #
Fairfield 1.097
Woodbridge 1.034
Houston 785
Ann Arbor 759
Chandler 616
Ashburn 536
Seattle 488
Serra 454
Cambridge 396
Sofia 386
Wilmington 383
Milan 357
New York 261
Beijing 203
Princeton 184
Ottawa 163
Lawrence 153
Medford 145
Jacksonville 109
London 107
Nanjing 98
Dong Ket 94
Abidjan 90
Des Moines 86
Dearborn 85
Vienna 83
Florence 61
Izmir 60
San Diego 49
Pisa 47
Redwood City 47
Bern 43
Hong Kong 41
Rome 41
Nanchang 40
Falls Church 29
Lucca 29
Washington 27
Changsha 24
Shenyang 24
Dakar 23
Kunming 23
Lagos 23
Bremen 22
Los Angeles 22
Lancaster 21
Brussels 19
Hebei 19
Jüchen 18
Ogden 17
Phoenix 16
Norwalk 13
Alessandria 12
Boulder 12
Guangzhou 12
Hefei 12
Redmond 11
Southend 11
Chicago 10
Nowy Sacz 10
Auburn Hills 9
Empoli 9
Groningen 9
Dallas 8
Livorno 8
Amsterdam 7
Boardman 7
Castelnovo di Sotto 7
Tianjin 7
Toronto 7
Bergen 6
Cairo 6
Frankfurt am Main 6
Hangzhou 6
Pescia 6
Pune 6
Atlanta 5
Buenos Aires 5
Council Bluffs 5
Indiana 5
Jiaxing 5
Pietrasanta 5
Poitiers 5
San Francisco 5
Singapore 5
Warsaw 5
Bogotá 4
Dubai 4
Esslingen am Neckar 4
Grafing 4
Istanbul 4
Jinan 4
Mountain View 4
Naples 4
Renton 4
Santiago 4
Shanghai 4
São Paulo 4
Tehran 4
Xian 4
Totale 10.260
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 270
Management of Chronic constipation in general practice 178
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 162
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 155
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 153
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 153
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 150
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 141
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 139
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 138
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 137
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 134
Management of chronic constipation in general practice. 133
Radionuclide evaluation of the lower gastrointestinal tract 132
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 131
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 129
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 125
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 124
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 120
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 119
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 117
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 116
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 114
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 113
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 113
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 112
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 111
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 110
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 110
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 108
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. 107
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 107
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors 107
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 106
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 105
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 105
Esophageal testing: What we have so far 104
Barrett's esophagus in 2016: From pathophysiology to treatment 104
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 102
Advancements in the use of manometry and impedance testing for esophageal functional disorders 102
Clinical and pathophysiological outcomes of the robotic-assisted Heller–Dor myotomy for achalasia: a single-center experience 102
Irritable bowel syndrome and chronic constipation: Fact and fiction 101
Esophageal motility abnormalities in gastroesophageal reflux disease 101
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 101
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 100
The natural history of gastro-esophageal reflux disease: A comprehensive review 100
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 100
Serum pepsinogen I and gastrin-17 levels are predictable of atrophic gastritis in patients with autoimmune thyroiditis and anti-gastric parietal cell autoantibodies. 99
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 98
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 96
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 96
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE) 95
Evaluation of latent links between irritable bowel syndrome and sleep quality 95
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 94
Achalasia with dense eosinophilic infiltrate responds to steroid therapy 94
GSTO: new marker of progression from barrett’s esophagus to adenocarcinoma. 92
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. 92
Optimal treatment of laryngopharyngeal reflux disease 92
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 92
Gastrointestinal involvement in systemic sclerosis 91
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 91
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 90
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus 90
Eating habits trajectories of students using university canteens 90
Vonoprazan fumarate for the management of acid-related diseases 90
Lactoferrin and probiotic can improve Helicobacter pylori eradication rate of triple standard therapy. 89
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 88
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 86
Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings 86
Presbifagia Esofagea 86
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease 84
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants 84
Are IBS patients alexithymic? 83
Updates in the field of non-esophageal gastroesophageal reflux disorder 83
Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies 82
Optimal management of constipation associated with irritable bowel syndrome 81
PP-6 BOLUS CLEARANCE TIME IS ASSOCIATED WITH REFLUX SEVERITY AND IT IS INVERSELY CORRELATED TO BASELINE IMPEDANCE VALUES IN ADOLESCENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 81
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 81
Patients Who Respond to PPI Therapy are Always Considered GERD Patients? a MII-pH Study. 80
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 80
Relationship of TT virus and Helicobacter pilori infections in gastric tissues of patients with gastritis 79
Jackhammer esophagus with and without esophagogastric junction outflow obstruction demonstrates altered neural control resembling type 3 achalasia 79
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 78
Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum 78
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 78
Current and future perspectives in the management of gastroesophageal reflux disease 78
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn 77
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 77
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 77
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal 76
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders 75
Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time 75
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 75
High Resolution and High Definition Anorectal Manometry 75
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 74
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 74
Perceptual and multiparametric analysis of the voice in GERD patients 73
Lactulose Breath Test to Assess Oro-cecal Transit Delay and Estimate Esophageal Dysmotility in Scleroderma Patients 72
Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives 72
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 72
Totale 10.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019698 0 0 0 0 0 0 0 0 0 0 384 314
2019/20203.089 319 188 472 202 267 327 299 247 310 166 216 76
2020/20211.385 104 83 89 145 109 59 91 109 142 107 102 245
2021/20221.652 17 76 37 68 322 258 59 80 104 64 92 475
2022/20232.078 265 305 176 153 200 311 19 149 325 13 134 28
2023/20241.555 183 183 235 168 226 311 92 57 45 53 2 0
Totale 13.460